Motus GI Holdings, Inc. (NASDAQ:MOTS) has received approval from the Israeli Ministry of Health to initiate commercial sales of the Pure-Vu EVS System in Israel. The Pure-Vu EVS System, which is already cleared by the U.S. FDA, integrates with standard and slim colonoscopes to improve visualization during colonoscopy. The system is designed to provide better-quality exams, especially for high acuity patients.